16 September 2022 · A summary of the implications of the UKs exit from the EU for clinical trial sites for both IMP and ATIMPs, including supply to and from Northern Ireland
7 September 2022 · Healthcare professionals who use vitamin D should be aware of the risks of toxicity and safe practice principles which may prevent patient harm
7 September 2022 · Healthcare professionals involved in the use of metolazone need to be aware of the differences between licensed and unlicensed products to ensure safe care.
26 August 2022 · A template Quality Technical Agreement for Outsourcing the Receipt, Storage, Preparation and Onward Supply of Marketed Cryopreserved ATMPs.
11 August 2022 · The intrathecal route is a high risk route of administration. It is essential to consider the properties of the medicinal product when assessing the risk
11 August 2022 · Morphine sulfate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Phenol products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Ropivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Hydrocortisone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration